AstraZeneca

Why your pensions could be dealt a body blow as Donald Trump eyes devastating tariffs for Britain's top pharmaceutical… This is Money09:35
Should you buy, sell or hold AstraZeneca stock before Q1 earnings? Zacks14:34
AstraZeneca staff donate toys to hospital children's ward Knutsford Guardian09:11
AstraZeneca unit hit with antitrust suit over Soliris Law36023:22
Arm CEO Rene Haas named as a new Ned at AstraZeneca Business Weekly17:25
Canberra PhD student discovers vaccine injury more common after Astrazeneca The Canberra Times20:38
AstraZeneca should get fired worker’s vaccine bias case trimmed Bloomberg Law17:27

Latest News

In the last 6 hours
AstraZeneca Korea reapplies for Lynparza reimbursement in prostate cancer Korea Biomedical Review02:29
Yesterday
AstraZeneca (LSE:AZN) and Daiichi Sankyo's ENHERTU Shows Promising Results in HER2 Breast Cancer Trial Simply Wall St22:16 21-Apr-25
New AstraZeneca breast cancer drug shows 'meaningful improvement' in survivability rates This is Money22:11 21-Apr-25
Enhertu poised to move first line in HER2+ breast cancer pharmaphorum21:26 21-Apr-25
Soliris® (eculizumab) Interchangeable Biosimilar Launches: Bkemv™ and Epysqli® JD Supra18:01 21-Apr-25
AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in… FiercePharma15:40 21-Apr-25
Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings? Zacks14:34 21-Apr-25
AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive… Benzinga13:16 21-Apr-25
In the last 7 days
AstraZeneca staff donate toys to hospital children's ward Knutsford Guardian09:11 20-Apr-25
AstraZeneca Unit Hit With Antitrust Suit Over Soliris Law36023:22 17-Apr-25
AstraZeneca Subsidiary Accused of Soliris Drug Market Monopoly Bloomberg Law19:15 17-Apr-25
AstraZeneca's Alexion accused of extending Soliris monopoly through sham patents in new suit FiercePharma17:05 17-Apr-25
Why your pensions could be dealt a body blow as Donald Trump eyes devastating tariffs for Britain's top pharmaceutical… This is Money09:35 17-Apr-25
Egypt signs deal with AstraZeneca to localise advanced genetic testing Amwal Al Ghad06:56 17-Apr-25
Canberra PhD student discovers vaccine injury more common after Astrazeneca The Canberra Times20:38 16-Apr-25
CUHK forges alliance with AstraZeneca Hong Kong Standard20:20 16-Apr-25
AstraZeneca Should Get Fired Worker’s Vaccine Bias Case Trimmed Bloomberg Law17:27 16-Apr-25
Arm CEO Rene Haas named as a new NED at AstraZeneca Business Weekly17:25 16-Apr-25
CUHK joins hands with AstraZeneca to boost research into clinical practice Hong Kong Standard13:09 16-Apr-25
Zydus Lifesciences Ltd leads losers in 'A' group The Business Standard10:59 16-Apr-25
AstraZeneca Logs Japan Growth Despite Price Cuts Scrip Pharma Intelligence04:07 16-Apr-25
Apellis, AstraZeneca break down their #FierceMadness 2025 Drug Ad Tournament success FiercePharma18:57 15-Apr-25
Glucagon-Like Peptide 1 Market Report 2025, Competitive Analysis of Novo Nordisk, Sanofi, Eli… Business Wire (Press Release)14:01 15-Apr-25
Stock Watch: Disappointing ACC Share Price Reactions For AstraZeneca And Lilly Scrip Pharma Intelligence13:54 15-Apr-25
AstraZeneca India surrenders marketing approval of prostate cancer drug The Business Standard11:42 15-Apr-25
AstraZeneca’s $130 million biomethane plant is a model for high-emitting industries Trellis11:32 15-Apr-25
AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drug The Times of India09:23 15-Apr-25
COVID-19 update includes province's announcement to pause AstraZeneca vaccinations CochraneNow00:06 15-Apr-25
In the last month
Top AstraZeneca exec sees more growth for drug giant in Greater Boston Boston Globe23:22 14-Apr-25
AstraZeneca’s Truqap recommended by NICE to treat advanced breast cancer PMLiVE12:27 14-Apr-25
NICE recommends AstraZeneca’s advanced breast cancer treatment Pharmaceutical Field10:53 14-Apr-25
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis Zacks08:20 14-Apr-25
UVa names AstraZeneca exec first head of future Manning Institute of Biotechnology Charlottesville Daily Progress, Virginia11:18 13-Apr-25
Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer FiercePharma20:31 11-Apr-25
AstraZeneca Chairman Says Drug Tariffs Would Harm Patients Bloomberg Law19:36 11-Apr-25
AstraZeneca’s AGM Approves All Resolutions, Marks Board Changes TipRanks17:34 11-Apr-25
UK Court of Appeal grants AstraZeneca an interim injunction against Glenmark’s generic dapagliflozin for type II… JD Supra17:23 11-Apr-25
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use Pharmaceutical Technology14:39 11-Apr-25
‘Landmark moment’ as new pill approved for common type of advanced breast cancer Belfast Telegraph00:08 11-Apr-25
AstraZeneca's quarterly earnings may undershoot; tariffs and a trade war pose the bigger… Proactive Investors (UK)16:18 10-Apr-25
Epithelioma Treatment Market Forecast and Company Analysis Report 2025-2034: Amgen, AstraZeneca, BeiGene, BMS, F.… GlobeNewswire (Press Release)14:58 10-Apr-25
AstraZeneca/Daiichi Sankyo’s Datroway approved by EC to treat breast cancer PMLiVE12:36 10-Apr-25
AstraZeneca and GSK retain defensive qualities, but tariff assault on sector could change that Proactive Investors (UK)12:14 10-Apr-25
Down 28% in 8 months, is AstraZeneca’s share price too cheap for me to pass up right now? Motley Fool (UK)11:13 10-Apr-25
Cheaper Soliris biosimilars reach the US market pharmaphorum09:41 10-Apr-25
Tariff fears wipe £14bn of UK pharma stocks: AstraZeneca and GSK tumble after Trump threats This is Money22:17 9-Apr-25
AstraZeneca Settles Covid-Shot Suit With Christian Salesman Bloomberg Law20:27 9-Apr-25
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today The Motley Fool16:15 9-Apr-25
Astrazeneca, BP, HSBC: The FTSE 100 stocks hit by Trump and China’s trade war City AM13:50 9-Apr-25
Trending tickers: Apple, Ford, BP and AstraZeneca Yahoo! UK & Ireland10:44 9-Apr-25
3 No-Brainer Growth Stocks to Buy for Less Than $100 The Motley Fool10:17 9-Apr-25
Daiichi Sankyo and AstraZeneca secure EU approval for Datroway London South East06:04 9-Apr-25
Astrazeneca (AZN) Stock Moves -1.35%: What You Should Know Zacks00:27 9-Apr-25
Onco-Innovations’ Inka Health Advances Pharmaceutical Analytics with AstraZeneca Collaboration TipRanks20:05 8-Apr-25
Rocket boosts preparations for gene therapy launch with new commercial chief from J&J,… FiercePharma16:28 8-Apr-25
AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains… JD Supra16:07 8-Apr-25
HBM Holdings Completes Subscription Shares Issuance to AstraZeneca TipRanks12:16 8-Apr-25
AZ, Daiichi get EU okay for breast cancer drug Datroway pharmaphorum11:37 8-Apr-25
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025 AstraZeneca (Press Release)10:03 8-Apr-25
DATROWAY® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2… Business Wire (Press Release)07:38 8-Apr-25
AstraZeneca’s Imfinzi regimen receives EC approval to treat resectable NSCLC PMLiVE12:55 7-Apr-25
EC approves AstraZeneca’s Imfinzi combo for NSCLC Pharmaceutical Technology11:21 7-Apr-25
AstraZeneca Korea receives approval for Imfinzi in limited-stage small cell lung cancer Korea Biomedical Review02:52 7-Apr-25
China, US and pay inject drama into AstraZeneca's AGM Yahoo! UK & Ireland11:25 6-Apr-25
AstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy Seeking Alpha16:14 5-Apr-25
AstraZeneca Pharma gets CDSCO nod to import and distribute TAGRISSO (Osimertinib) The Business Standard10:24 5-Apr-25
European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings Benzinga19:41 4-Apr-25
AstraZeneca, AbbVie Lose Minnesota Contract Pharmacy Law Suit Bloomberg Law18:24 4-Apr-25
Increases to AstraZeneca PLC's (LON:AZN) CEO Compensation Might Cool off for now Simply Wall St17:09 4-Apr-25
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers Pharmaceutical Technology15:33 4-Apr-25
AstraZeneca/Daiichi Sankyo’s Enhertu receives EC approval for HER2-low breast cancer PMLiVE12:34 4-Apr-25
AZ grabs pair of EU approvals for top cancer drugs pharmaphorum10:33 4-Apr-25
AstraZeneca gets EU approval for cancer treatments Enhertu and Imfinzi London South East09:50 4-Apr-25
Imfinzi-based perioperative regimen approved in the EU for resectable non-small cell lung cancer AstraZeneca (Press Release)08:48 4-Apr-25
Enhertu approved in the EU as first HER2-directed therapy for patients with HR-positive, HER2-low or HER2-ultralow… AstraZeneca (Press Release)08:48 4-Apr-25
London briefing: BP Chair to step down; AstraZeneca touts EU approval London South East07:58 4-Apr-25
AstraZeneca's Enhertu gets further EU approval London South East07:38 4-Apr-25
AstraZeneca's Enhertu gets fresh EU approval, Science Group ups Ricardo stake further ShareCast07:36 4-Apr-25
AstraZeneca’s Imfinzi Regimen Gains EU Approval for Lung Cancer TipRanks07:24 4-Apr-25
ENHERTU® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2… Business Wire (Press Release)07:03 4-Apr-25
AZ’s Oncology R&D Head On China’s Scientific Promise And True Innovation Scrip Pharma Intelligence03:36 4-Apr-25
AstraZeneca PLC (LON:AZN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders… Simply Wall St16:22 3-Apr-25
Nxera Pharma appoints AstraZeneca alum as inaugural commercial chief FiercePharma15:57 3-Apr-25
UK pharma escapes worst of Trump tariffs (for now) but uncertainty may keep pressure on shares Proactive Investors (US)14:35 3-Apr-25
Trending tickers: Nvidia, Tesla, Nike, AstraZeneca, Standard Chartered Yahoo! UK & Ireland12:27 3-Apr-25
UK pharma stocks avoid selloff London South East10:38 3-Apr-25
AstraZeneca and GSK shares rise on possible escape from new US tariffs Proactive Investors (UK)10:13 3-Apr-25
FTSE 100 pharma giants GSK and Astrazeneca appear to swerve Trump tariffs City AM09:21 3-Apr-25
Gastric Cancer Research Report 2025: A $14.5 Billion Market by 2032, Growing with a CAGR of 13% Featuring AstraZeneca,… GlobeNewswire (Press Release)09:06 3-Apr-25
Esophageal Cancer Market research 2024-2032 Featuring AstraZeneca, Takeda, Pfizer, Novartis, Amgen, Bristol-Myers… GlobeNewswire (Press Release)09:06 3-Apr-25
AstraZeneca remains top pick with leading American bank. Here's why Proactive Investors (UK)15:02 2-Apr-25
Myocardial Infarction Market Forecast Report 2025-2033 Featuring Major Players - Pfizer, BMS, AstraZeneca, Merck KGaA., … GlobeNewswire (Press Release)14:39 2-Apr-25
Top biotech deals of March 2025 Labiotech14:09 2-Apr-25
Central Bank of India leads losers in 'A' group The Business Standard11:03 2-Apr-25
Baxdrostat, AstraZeneca’s Next Big CVRM Bet Scrip Pharma Intelligence16:14 1-Apr-25
AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial Clinical Trials Arena12:54 1-Apr-25
AstraZeneca’s Imfinzi regimen approved by FDA to treat bladder cancer PMLiVE12:33 1-Apr-25
Big ambitions at Merck and AstraZeneca — along with a few giant pitfalls — reshape top ranks of the R&D 15 ENDPOINTS12:03 1-Apr-25
ACC25: AZ stakes its claim to the oral PCSK9 category pharmaphorum11:12 1-Apr-25
A £10,000 investment in AstraZeneca shares last Christmas is now worth… Motley Fool (UK)10:09 1-Apr-25
FDA approves AstraZeneca’s Imfinzi combo for bladder cancer Pharmaceutical Technology09:54 1-Apr-25
FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients Benzinga20:01 31-Mar-25
AstraZeneca bulks up Imfinzi's prowess with FDA nod in bladder cancer around surgery FiercePharma17:44 31-Mar-25
AstraZeneca Oral PCSK9 Prospects Pumped After Phase IIb Win Scrip Pharma Intelligence17:19 31-Mar-25
AstraZeneca’s cholesterol pill is set for Phase 3, but lags behind Merck rival ENDPOINTS17:05 31-Mar-25
​​AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C)… Business Wire (Press Release)17:00 31-Mar-25
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe Labiotech14:04 31-Mar-25
IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for… Business Wire (Press Release)12:03 31-Mar-25
AstraZeneca makes regulatory progress with Imfinzi, Calquence ShareCast11:43 31-Mar-25
IgniteData Advances Clinical Trial Efficiencies with Successful Deployment at Leading Cancer… PR Newswire (Press Release)11:00 31-Mar-25
AstraZeneca reports positive developments with assets in US and EU London South East09:52 31-Mar-25
Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for… AstraZeneca (Press Release)08:44 31-Mar-25
Imfinzi approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder… AstraZeneca (Press Release)08:44 31-Mar-25
Primark CEO steps down after complaint, AstraZeneca gets two new approvals ShareCast07:34 31-Mar-25
AstraZeneca’s Calquence Gains EU Recommendation for First-Line Mantle Cell Lymphoma Treatment TipRanks07:33 31-Mar-25

      
            
      
    view more headlines
   
      
      
      
22 Apr 02:29
   

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

AstraZeneca

Latest News

About our AstraZeneca news

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories